Innate Pharma buy metanicnor
Start price
07.09.14
/
50%
€8.63
Target price
09.03.15
€10.50
Performance (%)
19.99%
End price
09.03.15
€10.35
Summary
This prediction ended on 09.03.15 with a price of €10.35. The prediction had a final performance of 19.99%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innate Pharma | 1.361% | 1.361% | -21.716% | -35.813% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
Comments by metanicnor for this prediction
In the thread Innate Pharma diskutieren
IPH Kauf
eines der wenigen Biotech-Unternehmen in der Welt auf der angeborenen Immunität positioniert
das Geld wird es ermöglichen, halten die Ende 2017
(Laufzeit überschritten)